Associated Papers
Actionable mutations and targeted therapy in non-small cell lung cancer among Latin American and Hispanic patients: a systematic literature review of prognosis and meta-analysis.
Castañeda-González JP et al.
Translational Lung Cancer Research, 2025
Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.
Testoni E et al.
Embo Molecular Medicine, 2016
26758680 (PubMed )
Supplement: EMMM-8-105-s006.xlsx › H1623_mutations_cBio
Peutz-Jeghers syndrome: early clinical expression of a new STK11 gene variant.
Brito S et al.
Bmj Case Reports, 2015
Genetic and biochemical alterations in non-small cell lung cancer.
Johnson JL et al.
Biochemistry Research International, 2012
Genetic and epigenetic changes in lung carcinoma and their clinical implications.
Wen J et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2011
The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors.
Stehr H et al.
Molecular Cancer, 2011
21575214 (PubMed )
Supplement: 1476-4598-10-54-S3.XLS › mutations.txt
Select a paper to view details